Device Trial Radar · NCT00715026
Trilogy AB Acetabular Hip System Post Approval Study
Last checked: Nov 20, 2026Latest source record: Nov 26, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Zimmer BiometPublic (ZBH)
- Sponsor type
- Industry
- First posted
- Jul 15, 2008
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a post-approval study with prospective enrollment in the United States and a retrospective enrollment outside the United States to obtain functional, quality of life and radiographic data, which will facilitate assessment of the clinical performance of the Zimmer Trilogy AB Acetabular Hip System.
Conditions
- Osteoarthritis
- Avascular Necrosis
- Congenital Hip Dysplasia
- Traumatic Arthritis
Interventions
Trilogy AB Acetabular Hip Implant SystemDevice
Total hip replacement with ceramic on ceramic treatment surfaces.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Harris Hip ScoreTime frame: Pre-op, 3 Month Post-Op and Annual Post-Op visits through 5 Years
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Shrock Orthopedic Research
Fort Lauderdale, Florida
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.